Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and ramatroban

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with ramatroban in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(ramatroban)
Trials
(ramatroban)
Recent Studies (post-2010) (ramatroban)
9,1561875521421028

Protein Interaction Comparison

ProteinTaxonomy1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)ramatroban (IC50)
Thromboxane A2 receptor Homo sapiens (human)0.0107
Acyl-CoA:cholesterol acyltransferase Oryctolagus cuniculus (rabbit)0.311
Neuronal acetylcholine receptor subunit alpha-6Mus musculus (house mouse)0.311
Prostaglandin D2 receptor 2Homo sapiens (human)0.2289

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arima, M; Fukuda, T; Makino, S; Yukawa, T1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and ramatroban

ArticleYear
[Effect of BAY u3405-thromboxane A2 receptor antagonist, on biphasic airway responses induced by platelet-activating factor in actively sensitized guinea pigs].
    Arerugi = [Allergy], 1995, Volume: 44, Issue:7

    Topics: Airway Resistance; Animals; Carbazoles; Guinea Pigs; Male; Platelet Activating Factor; Platelet Aggregation Inhibitors; Receptors, Thromboxane; Sulfonamides; Thromboxane A2; Vaccination

1995